Purchase this article with an account.
Lawrence A. Yannuzzi; The Legend of Central Serous Chorioretinopathy. Invest. Ophthalmol. Vis. Sci. 201657(12):.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
Presentation Description :
Central Serous Chorioretinopathy (CSC) has been known as a distinct clinical entity for more than 150 years since originally described by Albrecht von Graefee. Numerous papers have been written on CSC for more than a century, describing its demographic features, its clinical manifestations, and course. However, its precise pathogenesis and treatment are still poorly understood. After brief historical comments, describing several of the landmarks in our understanding of the disease, current standards in its diagnosis and treatment will be reviewed. Recent observations at Vitreous-Retinal-Macula Consultants of New York, as well as elsewhere, will be covered with an emphasis on developments with Chronic-CSC. While acute CSC is generally believed to be a relatively benign disorder, not uncommonly there is evidence of visual loss in one or both eyes of elderly patients with chronic disease. Persistent and/or recurrent detachment may lead to Chronic-CSC with visual dysfunction from chorioretinal atrophy and other adverse changes, such as cystic degeneration of the retina and secondary choroidal neovascularization. Chronic-CSC based on recent study will be discussed, illustrating new observations involving the retinal pigment epithelium particularly the nature of associated pigment epithelial detachments. Finally, a rare variant of the disease….bullous retinal detachment in CSC…will also be presented to illustrate its peculiar risk factors, clinical spectrum, and ultimate visual outcome.
This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.
This PDF is available to Subscribers Only